Geisinger Researchers Receive $2.8 Million to Study Familial Hypercholesterolemia Screening Approaches
November 25, 2019
November 25, 2019
DANVILLE, Pennsylvania, Nov. 25 -- Geisinger Health issued the following news release:
* * *
- FH is the most common genetic cause of early, life-threatening cardiovascular disease
* * *
Researchers at Geisinger have received $2.8 million from the National Heart, Lung, and Blood Institute of the National Institutes of Health to improve detection of and family screening for familial hypercholesterolemia (FH). The project will be executed in coll . . .
* * *
- FH is the most common genetic cause of early, life-threatening cardiovascular disease
* * *
Researchers at Geisinger have received $2.8 million from the National Heart, Lung, and Blood Institute of the National Institutes of Health to improve detection of and family screening for familial hypercholesterolemia (FH). The project will be executed in coll . . .